OTCPK:GLPH (USA)
Gala Pharmaceutical Inc $ 0.00 0.00078 (22.29%)
Volume:
40,000
Avg Vol (1m):
82,609
Market Cap $:
505,000.00
Enterprise Value $:
505,000.00
P/E (TTM):
0.00
P/B:
0.00
Current and historical daily P/E ratio for GLPH (Gala Pharmaceutical Inc) from 2011 to Jan 24 2021. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Gala Pharmaceutical stock (GLPH) PE ratio as of Jan 24 2021 is 0.
More Details
Gala Pharmaceutical PE Ratio (TTM) Chart
EMBED
Gala Pharmaceutical PE Ratio (TTM) Historical Data
View and export this data going back to 2011. Start your Free Trial
Total 1271
- 1
- 2
- 3
- 4
- 5
- 6
- 15
| Gala Pharmaceutical PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2021-01-24 | 0.0 | 2020-11-19 | 0.0 |
| 2021-01-22 | 0.0 | 2020-11-18 | 0.0 |
| 2021-01-21 | 0.0 | 2020-11-17 | 0.0 |
| 2021-01-20 | 0.0 | 2020-11-16 | 0.0 |
| 2021-01-19 | 0.0 | 2020-11-13 | 0.0 |
| 2021-01-15 | 0.0 | 2020-11-12 | 0.0 |
| 2021-01-14 | 0.0 | 2020-11-11 | 0.0 |
| 2021-01-13 | 0.0 | 2020-11-10 | 0.0 |
| 2021-01-12 | 0.0 | 2020-11-09 | 0.0 |
| 2021-01-11 | 0.0 | 2020-11-06 | 0.0 |
| 2021-01-08 | 0.0 | 2020-11-05 | 0.0 |
| 2021-01-07 | 0.0 | 2020-11-04 | 0.0 |
| 2021-01-06 | 0.0 | 2020-11-03 | 0.0 |
| 2021-01-05 | 0.0 | 2020-11-02 | 0.0 |
| 2021-01-04 | 0.0 | 2020-10-30 | 0.0 |
| 2021-01-01 | 0.0 | 2020-10-29 | 0.0 |
| 2020-12-31 | 0.0 | 2020-10-28 | 0.0 |
| 2020-12-30 | 0.0 | 2020-10-27 | 0.0 |
| 2020-12-29 | 0.0 | 2020-10-26 | 0.0 |
| 2020-12-28 | 0.0 | 2020-10-23 | 0.0 |
| 2020-12-24 | 0.0 | 2020-10-22 | 0.0 |
| 2020-12-23 | 0.0 | 2020-10-21 | 0.0 |
| 2020-12-22 | 0.0 | 2020-10-20 | 0.0 |
| 2020-12-21 | 0.0 | 2020-10-19 | 0.0 |
| 2020-12-18 | 0.0 | 2020-10-16 | 0.0 |
| 2020-12-17 | 0.0 | 2020-10-15 | 0.0 |
| 2020-12-16 | 0.0 | 2020-10-14 | 0.0 |
| 2020-12-15 | 0.0 | 2020-10-13 | 0.0 |
| 2020-12-14 | 0.0 | 2020-10-12 | 0.0 |
| 2020-12-11 | 0.0 | 2020-10-09 | 0.0 |
| 2020-12-10 | 0.0 | 2020-10-08 | 0.0 |
| 2020-12-09 | 0.0 | 2020-10-07 | 0.0 |
| 2020-12-08 | 0.0 | 2020-10-06 | 0.0 |
| 2020-12-07 | 0.0 | 2020-10-05 | 0.0 |
| 2020-12-04 | 0.0 | 2020-10-02 | 0.0 |
| 2020-12-03 | 0.0 | 2020-10-01 | 0.0 |
| 2020-12-02 | 0.0 | 2020-09-30 | 0.0 |
| 2020-12-01 | 0.0 | 2020-09-29 | 0.0 |
| 2020-11-30 | 0.0 | 2020-09-28 | 0.0 |
| 2020-11-27 | 0.0 | 2020-09-25 | 0.0 |
| 2020-11-26 | 0.0 | 2020-09-24 | 0.0 |
| 2020-11-25 | 0.0 | 2020-09-23 | 0.0 |
| 2020-11-24 | 0.0 | 2020-09-22 | 0.0 |
| 2020-11-23 | 0.0 | 2020-09-21 | 0.0 |
| 2020-11-20 | 0.0 | 2020-09-18 | 0.0 |
Gala Pharmaceutical PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Compare
LSE:PYC
OTCPK:PRTX
OTCPK:PPCB
OTCPK:BTHE
TSXV:IBT
XCNQ:DOSE
TSXV:APC
OTCPK:RSPI
XCNQ:LILY
OTCPK:OBMP
ASX:MEB
XSAT:CLINE B
OTCPK:AMBS
WAR:RDG
ASX:ACL
OTCPK:TNTY
TSXV:MFS
OTCPK:VODG
OTCPK:GOVX
ASX:RAC
Traded in other countries
GLPH.USA
Address
18881 Von Karman Avenue, Suite 1440, Irvine, CA, USA, 92612
Gala Pharmaceutical Inc is a United States-based company engaged in the hemp and cannabidiol (CBD) industry. It is focused on the development, research, and commercialization of products derived from the hemp and cannabis plant. It is focused on CBD flavored thin-film strip which is an advanced method of providing CBD for the dietary supplement. The services offered by the company are the development of cannabinoid-based health and wellness products; development of medical grade compounds; licensing of proprietary testing, genetics, labeling and packaging, tracking, production, and standardization methods for the medicinal herb industry. The group earns revenue from the sale of products related to hemp and CBD, including modified electronic cigarettes and vape pens.